Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$0.46 - $0.79 $1,150 - $1,975
-2,500 Reduced 51.49%
2,355 $1,000
Q1 2023

May 12, 2023

SELL
$0.44 - $0.88 $10 - $21
-24 Reduced 0.49%
4,855 $2,000
Q4 2022

Feb 10, 2023

SELL
$0.45 - $1.29 $214 - $614
-476 Reduced 8.89%
4,879 $2,000
Q3 2022

Nov 14, 2022

BUY
$0.78 - $1.75 $978 - $2,196
1,255 Added 30.61%
5,355 $3,000
Q2 2022

Aug 10, 2022

BUY
$0.96 - $2.36 $3,548 - $8,722
3,696 Added 914.85%
4,100 $7,000
Q1 2022

May 04, 2022

SELL
$2.27 - $4.03 $7,481 - $13,282
-3,296 Reduced 89.08%
404 $1,000
Q3 2021

Nov 05, 2021

BUY
$2.91 - $3.79 $10,767 - $14,023
3,700 New
3,700 $10,000

Others Institutions Holding BTCY

# of Institutions
1
Shares Held
834
Call Options Held
0
Put Options Held
0

About BIOTRICITY INC.


  • Ticker BTCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 50,431,200
  • Market Cap $12.6M
  • Description
  • Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile ...
More about BTCY
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.